The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...
The FDA has approved Rybrevant in combination with carboplatin and pemetrexed for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer ...
Information about the poll methodology, demographics of the respondents and a map of the geographic regions for this week’s Star Tribune/MPR News/KARE 11 Minnesota Poll.
Findings showed comparable exposures to atezolizumab between Tecentriq Hybreza and intravenous atezolizumab. The confirmed ORR was 9% (95% CI, 5-13) in the Tecentriq Hybreza arm and 8% (95% CI, 4-14) ...
The Food and Drug Administration (FDA) has approved Sarclisa ® (isatuximab-irfc) in combination with bortezomib, lenalidomide and dexamethasone (VRd) for the treatment of patients with newly diagnosed ...